Target intelligence / Profile preview

Bacterial cell membrane phospholipid complex

Molecular classification
Other (structural lipid complex)
01

Overview

The **bacterial cell membrane phospholipid complex** refers collectively to the diverse array of amphiphilic lipids—primarily glycerophospholipids—that form the structural basis of all bacterial cytoplasmic membranes. These complexes are not single molecular targets but rather essential components that create a semi-permeable barrier, regulate transport, maintain cellular integrity, and modulate interactions with proteins. The main classes include phosphatidylethanolamine, phosphatidylglycerol, cardiolipin, among others; their composition varies widely across species[5][6]. In Gram-negative bacteria, these complexes are critical for maintaining outer membrane asymmetry and function as a defense against antibiotics by preserving envelope integrity[1]. While not considered classical drug targets like receptors or enzymes, they are exploited by certain antibiotics such as polymyxins that disrupt their structure. However, "bacterial cell membrane phospholipid complex" is not a precise molecular target but rather describes an essential structural feature shared by all bacteria; thus it is too broad for use as a canonical therapeutic target name[1][2][5].

Other names
Bacterial membrane phospholipidsBacterial lipid bilayerPhospholipid bilayer (bacteria)Bacterial cytoplasmic membrane lipids
02

Mechanism of action

Disruption of the phospholipid bilayer leading to increased permeability and cell death (for polymyxins and daptomycin)

03

Biological functions

Structural component of cell membranesRegulation of membrane fluidity and permeabilityModulation of protein-membrane interactionsBarrier to external environment
04

Disease associations

Infection (as a barrier in pathogenic bacteria)Antibiotic resistance (by maintaining outer membrane integrity)Other (general role in bacterial viability)
05

Safety considerations

Toxicity to human cells due to similarity between some bacterial and eukaryotic phospholipids when using non-selective agents like polymyxins.
06

Interacting drugs

Polymyxins (e.g., colistin, polymyxin B)

1 more in the full profile.

Beyond the preview

Go deeper on Bacterial cell membrane phospholipid complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell membrane phospholipid complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call